First characterization of a Providencia stuartii clinical isolate from a Tunisian intensive care unit coproducing VEB-1-a, OXA-2, qnrA6 and aac(6′)-Ib-cr determinants

A clinical Providencia stuartii isolate SM662 was recovered from a patient hospitalized in the intensive care unit at the Military hospital, Tunisia. This isolate was resistant to penicillins, cephalosporins, aminoglycosides and fluoroquinolones. A marked in vitro synergy between ceftazidime or cefo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahrouki, Sihem, Chihi, Hela, Bourouis, Amel, Ben Moussa, Mohamed, Belhadj, Omrane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427477/
https://www.ncbi.nlm.nih.gov/pubmed/24378226
http://dx.doi.org/10.1016/j.bjid.2013.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427477/
https://www.ncbi.nlm.nih.gov/pubmed/24378226
http://dx.doi.org/10.1016/j.bjid.2013.10.004

Ejemplares similares